Interleukin 20: Discovery, receptor identification, and role in epidermal function

被引:464
作者
Blumberg, H
Conklin, D
Xu, WF
Grossmann, A
Brender, T
Carollo, S
Eagan, M
Foster, D
Haldeman, BA
Hammond, A
Haugen, H
Jelinek, L
Kelly, JD
Madden, K
Maurer, MF
Parrish-Novak, J
Prunkard, D
Sexson, S
Sprecher, C
Waggie, K
West, J
Whitmore, TE
Yao, L
Kuechle, MK
Dale, BA
Chandrasekher, YA
机构
[1] Zymogenet Inc, In Vitro Biol, Seattle, WA 98102 USA
[2] Zymogenet Inc, Dept Genet, Seattle, WA 98102 USA
[3] Zymogenet Inc, Biomol Informat, Seattle, WA 98102 USA
[4] Zymogenet Inc, Funct Cloning, Seattle, WA 98102 USA
[5] Univ Washington, Dept Oral Biol & Med Dermatol, Seattle, WA 98195 USA
关键词
D O I
10.1016/S0092-8674(01)00187-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A structural, profile-based algorithm was used to identify interleukin 20 (IL-20), a novel IL-10 homolog. Chromosomal localization of IL-20 led to the discovery of an IL-10 family cytokine cluster. Overexpression of IL-20 in transgenic (TG) mice causes neonatal lethality with skin abnormalities including aberrant epidermal differentiation. Recombinant IL-20 protein stimulates a signal transduction pathway through STAT3 in a keratinocyte cell line, demonstrating a direct action of this ligand. An IL-20 receptor was identified as a heterodimer of two orphan class II cytokine receptor subunits. Both receptor subunits are expressed in skin and are dramatically upregulated in psoriatic skin. Taken together, these results demonstrate a role in epidermal function and psoriasis for IL-20, a novel cytokine identified solely by bioinformatics analysis.
引用
收藏
页码:9 / 19
页数:11
相关论文
共 44 条
[1]   IL-10 is a key cytokine in psoriasis -: Proof of principle by IL-10 therapy:: A new therapeutic approach [J].
Asadullah, K ;
Sterry, W ;
Stephanek, K ;
Jasulaitis, D ;
Leupold, M ;
Audring, H ;
Volk, HD ;
Döcke, WD .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (04) :783-794
[2]   Interleukin-10 in cutaneous disorders:: implications for its pathophysiological importance and therapeutic use [J].
Asadullah, K ;
Sabat, R ;
Wiese, A ;
Döcke, WD ;
Volk, HD ;
Sterry, W .
ARCHIVES OF DERMATOLOGICAL RESEARCH, 1999, 291 (12) :628-636
[3]  
BECKER TC, 1994, METHOD CELL BIOL, V43, P161
[4]   The pathogenesis of psoriasis: Immunological facts and speculations [J].
Bos, JD ;
De Rie, MA .
IMMUNOLOGY TODAY, 1999, 20 (01) :40-46
[5]   NORMAL KERATINIZATION IN A SPONTANEOUSLY IMMORTALIZED ANEUPLOID HUMAN KERATINOCYTE CELL-LINE [J].
BOUKAMP, P ;
PETRUSSEVSKA, RT ;
BREITKREUTZ, D ;
HORNUNG, J ;
MARKHAM, A ;
FUSENIG, NE .
JOURNAL OF CELL BIOLOGY, 1988, 106 (03) :761-771
[6]   Transgenic mice expression IFN-gamma in the epidermis have eczema, hair hypopigmentation, and hair loss [J].
Carroll, JM ;
Crompton, T ;
Seery, JP ;
Watt, FM .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 108 (04) :412-422
[7]   The epidermal phenotype during initiation of the psoriatic lesion in the symptomless margin of relapsing psoriasis [J].
Castelijns, FACM ;
Gerritsen, MJP ;
van Vlijmen-Willems, IMJJ ;
van Erp, PEJ ;
van de Kerkhof, PCM .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1999, 40 (06) :901-909
[8]   Isolation of Angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning [J].
Davis, S ;
Aldrich, TH ;
Jones, PF ;
Acheson, A ;
Compton, DL ;
Jain, V ;
Ryan, TE ;
Bruno, J ;
Radziejewski, C ;
Maisonpierre, PC ;
Yancopoulos, GD .
CELL, 1996, 87 (07) :1161-1169
[9]   TOXICOLOGICAL AND PATHOLOGICAL APPLICATIONS OF PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA), A NOVEL ENDOGENOUS MARKER FOR CELL-PROLIFERATION [J].
DIETRICH, DR .
CRITICAL REVIEWS IN TOXICOLOGY, 1993, 23 (01) :77-109
[10]   Characterization and quantitation of NF-κB nuclear translocation induced by interleukin-1 and tumor necrosis factor-α -: Development and use of a high capacity fluorescence cytometric system [J].
Ding, GJF ;
Fischer, PA ;
Boltz, RC ;
Schmidt, JA ;
Colaianne, JJ ;
Gough, A ;
Rubin, RA ;
Miller, DK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (44) :28897-28905